News | May 1, 2022

Independent Research Presented at Pediatric Endocrine Society Annual Meeting

BioMarin congratulates Dr. Andrew Dauber, Chief of Endocrinology at Children’s National Hospital in Washington, D.C., who has recently presented independent research to study a BioMarin therapy, in selected genetic causes of short stature.


Explore Topics